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Edited by Horst FeldmannAbstract Haem-copper oxidases are the last components of the
respiratory chains in aerobic organisms. These membrane-bound
enzymes energetically couple the electron transfer (eT) reactions
associated with reduction of dioxygen to water, to proton
pumping across the membrane. Even though the mechanism of
proton pumping at the molecular level still remains to be
uncovered, recent progress has presented us with the structural
features of the pumping machinery and detailed information
about the eT and proton-transfer reactions associated with the
pumping process.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Haem-copper respiratory oxidases catalyse the reduction of
dioxygen to water:
O2 þ 4Hþ þ 4e ! 2H2O
Because the electrons and protons are taken up from opposite
sides of the membrane, the reaction results in a net charge
separation across the membrane corresponding to the trans-
location of one positive charge from the membrane negative
(N) side to the positive (P) side. In addition, in most oxidases
studied to date, the reaction is also coupled to proton pumping
across the membrane, which results in an overall translocation
of two positive charges across the membrane per electron
transferred to O2. In cytochrome c oxidases (CcOs) the elec-
tron donor is cytochrome c, which in the enzymes from, e.g.,
bovine heart, Rhodobacter sphaeroides (Fig. 1) and Paracoccus
denitriﬁcans donates an electron to a dinuclear copper centre
(CuA). The electrons are then transferred from CuA consecu-
tively to a haem group, haem a, and to a haem-copper centre* Corresponding authors. Fax: +46-8-153679.
E-mail addresses: andreas@dbb.su.se (A. Namslauer),
peterb@dbb.su.se (P. Brzezinski).
Abbreviations: CcO, cytochrome c oxidase; eT, electron transfer; pT,
proton-transfer; N-side, negative side of the membrane; P-side,
positive side of the membrane
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doi:10.1016/j.febslet.2004.04.027(haem a3-CuB), which is the catalytic site of these CcOs. Often
a tyrosine, Y(I-288)1, which is presumably redox-active, is also
included as being part of the catalytic site (see Fig. 1B).
In bacterial oxidases two proton-transfer (pT) pathways,
called the D- and the K-pathway, leading from the cytoplasmic
side [the N-side of the membrane] towards the catalytic site,
have been identiﬁed on the basis of results from studies on
mutant oxidases (see e.g., [1–7]) and inspection of the available
X-ray crystal structures [8–12] (see Fig. 1).
Results from numerous studies indicate that the D-pathway
is used for uptake of both substrate protons and protons to be
pumped during the reduction of oxygen, while the K-pathway
is presumably used during the reduction of the catalytic site,
prior to binding of dioxygen (see e.g., [13–16]).
Here, we review recent results from functional and structural
studies on haem-copper oxidases that have provided
information about the mechanisms of proton translocation in
these enzymes. Speciﬁcally, we discuss the temporal and en-
ergetic coupling between the electron transfer (eT) and pT
reactions associated with oxygen reduction and the translo-
cation of the pumped protons, focussing on the role of speciﬁc
groups within the D-pathway.2. Structural features of the proton translocation machinery
Fig. 1B shows selected parts of the structure of CcO from R.
sphaeroides. The four redox-active cofactors are shown to-
gether with amino-acid residues in the pT pathways. The so-
called D-pathway is named after an aspartate (D(I-132)),
which constitutes the entrance point of the pathway. An array
of water molecules, lined with polar amino-acid residues, leads
to a glutamate (E(I-286)), located 25 A ‘‘above’’ the surface,
at approximately equal distances from haems a and a3,
respectively.
Since the D-pathway is used for uptake of both the substrate
protons, which are transferred to the catalytic site, and
pumped protons, which are transferred to a proton-accepting
group in the exit pathway (see below), there must be a
branching point within the pathway. The results from several
studies suggest that this branching point is located at E(I-286)1 Amino-acid residue and mutant-enzyme nomenclature: N(I-139),
Asparagine of subunit I at position 139, ND(I-139), replacement of
N(I-139) by aspartic acid Unless otherwise indicated amino-acid
numbering is according to the Rhodobacter sphaeroides CcO sequence.
ation of European Biochemical Societies.
Fig. 1. The crystal structure of CcO from R. sphaeroides (1m56.pdb in
the Protein Data Bank, [11]). The structure of the four-subunit CcO
together with the redox-active cofactors (blue) and all structurally re-
solved water molecules (red spheres) are shown in (A). Subunit I is
shown in brown, subunit II in green, subunit III in silver and subunit
IV in magenta. The approximate location and thickness of the lipid
membrane are indicated by the dotted lines. The arrows indicate the
depth at which the haems and CuB are located in the membrane (all
three at the same approximate depth). A more detailed view of the
redox-active cofactors and amino acid residues in the pT pathways
(dotted arrows) discussed in the text is given in (B). The histidine li-
gands of CuB are also shown. Only the water molecules in the D- and
K-pathways are shown, other water molecules are excluded for clarity.
The location of the redox-inactive Mg-ion is also indicated. The ﬁgures
were prepared using the Visual Molecular Dynamics software [74].
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function as the primary proton acceptor of pumped protons
(pump site), e.g., one of the histidines ligated to CuB [9,21], or
one of the D-ring propionates of the haems [18,19,22,23].
It has been shown that the highly conserved arginines (R
(I-481)and R(I-482), see Fig. 1B), which are salt bridged to the
D-ring propionates of the haems, are important for proton
pumping. In the bo3 quinol oxidase from Escherichia coli,
proton pumping was impaired in mutant enzymes in which
R(I-481) was substituted by asparagine or leucine [18], while in
the CcO from R. sphaeroides the RK(I-481) mutant enzyme
was able to pump protons but the activity was considerably
lower than with wild-type CcO in coupled vesicles (i.e., duringturnover with an electrochemical gradient across the mem-
brane) [22]. Results from FT-IR experiments [23] indicate that
the D-ring propionates are stabilised in their anionic state in
the oxidised CcO, and are able to function as proton acceptors/
donors.
From the R(I-481)/R(I-481)/propionates cluster, the protons
are probably transferred towards a hydrogen-bonded network
of water molecules as well as polar and acidic amino acid
residues, located between the haem groups and the p-side of
the membrane surface (cf. Fig. 1A). Results from electrostatic
calculations suggest that in this region there is an assembly of
interacting acidic groups, which could function as proton-
shuttling groups [24].
In the crystal structures determined so far there are no water
molecules resolved neither in the hydrophobic cavity between
E(I-286) and the catalytic site, nor between E(I-286) and the
D-ring propionates, and no hydrogen-bonded proton pathway
is observed (cf. Fig. 1B). Thus, the question arises as to how
protons are transferred through these hydrophobic regions. As
evident from theoretical calculations, there is space for water
molecules in these regions [17,25]. Results from computer
modelling have suggested that the water molecules form a
branched chain, connecting E(I-286) with the binuclear centre
and the D-ring propionate of haem a3 [19,20]. Most probably
these water molecules are structurally disordered and the hy-
drogen-bonded water chains may be formed only transiently
during catalysis. It was recently suggested by Wikstr€om et al.
[19] that a reorganisation of these water molecules could
control the pT rate (cf. proton gating) if the orientation of the
water molecules could be controlled, through electrostatic in-
teractions with the redox centres.
Another putative pT pathway, the so-called H-pathway, was
identiﬁed in the structure of CcO from bovine mitochondria
and suggested by Yoshikawa et al. [26,27] to be used for
proton pumping. Results from recent studies, in which the
gene for the bovine CcO was mutated and expressed in human
cell lines, support the idea that one of the key residues in the
H-pathway (D(I-51), bovine CcO numbering) is involved in
proton translocation [28]. However, the H-pathway is only
partly conserved in the bacterial oxidases and no eﬀect on
proton pumping was observed upon substitution of these res-
idues [6,29]. Thus, at this point, the role of the H-pathway, if
any, in the bacterial oxidases is unclear.3. Transfer of substrate protons through the D-pathway
3.1. The oxygen reduction reaction
The individual steps during oxygen reduction can be
studied using the so-called ﬂow-ﬂash technique. Brieﬂy, the
reduced, CO-bound CcO is mixed with an oxygen-saturated
solution in a stopped-ﬂow apparatus. A short time after
mixing, the CO ligand is photodissociated using a laser ﬂash.
Because oxygen and CO bind to the same site, haem a3, the
oxygen binding is rate-limited by the CO-oﬀ rate (s ﬃ 30 s).
Hence, if the sample is illuminated at t 30 s, the light ﬂash
sets the starting point of the reaction. The binding of oxygen
and its subsequent stepwise reduction (concomitant with the
oxidation of the enzyme) can be followed time resolved us-
ing spectroscopic techniques. On the basis of the results
from these, as well as other measurements, information is
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action of the reduced CcO with O2 and the transition times
between these intermediates (as summarised in Fig. 2, for
review, see [30–32]). Dioxygen binds to ferrous haem a3 with
a second-order rate constant of 108 M1 s1, forming state
A. Next, the O–O bond is broken forming a oxo-ferryl state
at haem a3 (denoted PR) and a hydroxide ion at CuB with a
time constant of 50 ls. During this transition, an electron
is transferred to the catalytic site from haem a, whereas the
other three electrons and the proton needed to break the O–
O bond are taken from within the catalytic site. In the PR
state there is an uncompensated negative charge at the cat-
alytic site, which is neutralised by a proton during the next
transition, the formation of the F state with a time constant
of 100 ls (at pH 6 8). Concomitantly, with the proton
uptake upon F formation the electron on CuA equilibrates
with haem a. The fully oxidised enzyme, denoted O, is
formed with a time constant of 1.2 ms, associated with
proton uptake from the bulk solution. Note that this state
probably has two hydroxide ions in the catalytic site (cf.
[33,34]) and may diﬀer from the relaxed (as isolated) oxi-
dised CcO (see [16,35–37] for detailed discussions on this
issue). Upon reaction of the reduced CcO with O2, protons
are pumped during the PR ! F and F! O transitions
[38,39].R Fea32+ CuB+ Y(I-288)OH
- O2 binding10 µs
A
PR
- pT to a group at the catalytic site, 
probably Y(I-288)
- pT from the bulk solution
- eT from CuA to haem a
100 µs
Fea34+=O2- CuB2+-OH- Y(I-288)O-
- O-O bond breakage
- Formation of an oxo-ferryl state at haem a3
- eT from haem a to the catalytic site
- Internal pT within the catalytic site, 
from Y(I-288) to CuB2+-OH-
Fea32+-O-O CuB+ Y(I-288)OH
50 µs
F
O
- pT to the oxo-ferryl group at haem a3,
formation of a hydroxyl group 
- pT from the bulk solution
- eT from CuA and haem a to the catalytic site
1.2 ms
Fea34+=O2- CuB2+-OH- Y(I-288)OH
Fea33+-OH- CuB2+-OH- Y(I-288)OH
Fig. 2. A scheme illustrating the reaction between fully reduced CcO
and oxygen. The one-letter codes denote the commonly used abbre-
viations for the intermediate states. The suggested structures of the
intermediate states at the catalytic site are shown in the rectangles to
the right (Fea3: the iron ion of haem a3, CuB: the copper B ion and
Y(I-288): a tyrosine close to the haem-copper centre). The time con-
stants given for the transitions are those observed with CcO from R.
sphaeroides.3.2. The PR ! F transition, a two-step pT
The PR ! F transition is associated with proton uptake
from the bulk solution. Since the electron is transferred to the
catalytic site in the previous step, i.e., when PR is formed
(s ﬃ 50 ls), studies of the PR ! F transition (s ﬃ 100 ls at pH
6 8) make it possible to speciﬁcally investigate pT to the cat-
alytic site through the D-pathway. The protonation event at
the catalytic site (presumably of Y(I-288) [40]) results in a shift
of the peak in the a-region of the optical absorbance spectrum
from 607 to 580 nm. The transition is also associated with
equilibration of the electron between CuA to haem a (see
Fig. 2). Hence, the events associated with F formation can be
followed in three ways using optical absorption spectroscopy;
(1) by monitoring absorbance changes at 580 nm, (2) by
measuring the proton uptake from an unbuﬀered solution
using a pH-sensitive dye, or (3) by monitoring absorbance
changes associated with the oxidation of CuA and reduction of
haem a.
The glutamate in the upper part of the D-pathway (E(I-286))
and the aspartate (D(I-132)) at the surface are both conserved
in a large group of the mitochondrial-type haem-copper ox-
idases and have been shown to be necessary for the function of
these enzymes (see Fig. 1B). Results from mutagenesis studies
of CcO from R. sphaeroides and P. denitriﬁcans as well as the
quinol oxidase from E. coli have shown that, exchanging the
glutamate for a non-protonatable group (e.g., glutamine or
alanine) results in mutant oxidases with almost no steady-state
activity [3,6,7,41,42]. Furthermore, it was shown that these
mutant enzymes were not able to form intermediate F [13,43–
45]; i.e., when the fully reduced mutant CcO reacts with oxy-
gen, the reaction stops at the PR-intermediate. When E(I-286)
was substituted with the protonatable residue aspartate, the
steady-state activity was lower than that of the wild-type CcO
[7], and the PR ! F and F! O transitions were slowed [46].
Similarly, when E(I-286) was ‘‘relocated’’ to a diﬀerent posi-
tion in the D-pathway in CcO from R. sphaeroides [47,48], the
pumping stoichiometry was lowered, the steady-state activity
was lowered and the rates of the PR ! F and F! O transi-
tions were slowed. Taken together, these observations imply
that E(I-286) is involved in proton delivery to the binuclear
centre upon F and O formation, and presumably also in the
translocation of pumped protons.
When D(I-132) at the entrance of the pathway is exchanged
for asparagine or alanine, the activity of the mutant oxidases
was substantially decreased and the mutant enzymes did not
pump protons [1,4,6,7]. The DN(I-132) CcO from R. sph-
aeroides does form F upon reaction with oxygen with the same
rate as the wild-type CcO, but without concomitant proton
uptake from the bulk solution [49]. These results indicate that
the DN(I-132) mutation inhibits proton uptake from the bulk
solution and that the F intermediate can be formed using an
internal proton within the D-pathway. In addition, no eT from
CuA to haem a was observed during the F formation, indi-
cating that the eT is controlled by the proton uptake [49]. A
similar behaviour was observed with the wild-type CcO when
the ﬂow-ﬂash experiment was performed with zinc ions present
in the CcO solution, interpreted in terms of Zn2þ binding to
the CcO surface near the entrance of the D-pathway, resulting
in impaired proton uptake from the bulk solution [50].
Taken together, the results discussed above point towards a
two-step mechanism of pT to the catalytic site through the D-
pathway in which the proton is ﬁrst taken internally, pre-
FCuA+
Fea3+ Fea34+=O2 CuB2+-OH
EI-286H YI-288O-
DI-132(H)
−
−
PR
CuA2+
Fea2+ Fea34+=O2 CuB2+-OH
EI-286H YI-288OH
DI-132(H)
−
−
F
CuA+
Fea3+ Fea34+=O2 CuB2+-OH
EI-286- YI-288OH
DI-132(H)
−
−
kobs ≅ 1.1 · 104 s-1 (at pH < 8)
H+ (bulk)
internal proton transfer:
kH0 = 1.1 · 104 s-1(blocked in EQ(I-286))
proton uptake from bulk solution:
k1, k-1 >> kH0(blocked in DN(I-132) and with Zn2+)
kH0 k1
k
-1
Fig. 3. The two-step mechanism of pT through the D-pathway during the PR ! F transition (observed rate constant kobs). The internal pT from E(I-
286) to the catalytic site (rate constant k0H) is rate limiting for the reaction and E(I-286) is in rapid proton equilibrium with the bulk solution (rate
constants k1, k1  k0H).
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from the bulk solution (see Fig. 3) [49–51]. Hence, the ob-
served rate of F formation is limited by the pT from E(I-286)
to the catalytic site, and probably determined by the reorga-
nisation of water molecules or a conformational change of the
E(I-286) side chain (see below).3.3. The pH dependence of the pT reactions
In the mechanism described above, the observed rate of
F-formation (i.e., pT to the catalytic site through E(I-286))
depends on the fraction protonated internal proton donor
(E(I-286)). Hence, the observed pKa in the pH-dependence of
the rate reﬂects the apparent pKa of E(I-286). In the wild-type
CcO from R. sphaeroides, the PR ! F rate followed a titration
curve with a pKa of 9.4 [51] (see Fig. 4), i.e., considerably
higher than the pKa value of a glutamic acid in water solution
(4.5). The increased pKa is explained by the low dielectric
constant in the protein interior, where the uncharged (pro-
tonated) form is stabilised. An analysis of the X-ray structure6 7 8 9 10 11
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Fig. 4. The pH dependence of the observed rate of the PR ! F (circles)
(from [51]) and F to O (squares) transitions. The solid lines represent
standard titration curves with one and two pKa values, for the PR ! F
and F! O transitions, respectively. The experimental data of the
PR ! F transition rate were best ﬁtted to a pKa value of 9.4 and a
maximal rate constant of 1.1 104 s1 (i.e., the rate constant with the
titrating group fully protonated). The F! O data were ﬁtted with two
pKa values, pKað1Þ ﬃ 6:4 and pKað2Þ ﬃ 8:9, a maximal rate constant of
1.1 103 s1 and a background rate constant of 140 s1 (i.e., the
transition rate with both titrating groups unprotonated). For experi-
mental conditions, see [51].supports the conclusion that E(I-286) is protonated at neutral
pH, forming a hydrogen bond with the carbonyl oxygen of
M(I-107) [11]. This observation is also consistent with results
from experiments using FT-IR spectroscopy, showing high
pKa values (>9) of the corresponding glutamate in haem-
copper oxidases from diﬀerent species [52,53].
In the high-pH range, the pH dependence of the rate of the
next transition, F! O, titrates with a similar pKa (8.9) to
that observed for the PR ! F transition (Fig. 4). However, the
pH dependence of the F! O transition rate is more complex
displaying a titration also in the low-pH region (pKa ﬃ 6:4).
The F! O transition rate has been modelled to be a function
of the rate of pT to the catalytic site, times the fraction of the F
intermediate reduced with another electron [54]. Thus, the
higher pKa is likely to be associated with the pT, reﬂecting the
pKa of E(I-286), while the lower pKa could be associated with
another titrating protonatable group, interacting with the
redox site(s).4. Transfer of pumped protons through the D-pathway
So far, we have focused on the transfer mechanism of sub-
strate protons to the catalytic site through the D-pathway
during speciﬁc reaction steps and not discussed the fact that
during these transitions protons are also pumped. It is inter-
esting to note that the actual reduction of the dioxygen mol-
ecule resulting in the O–O bond breaking occurs already in the
ﬁrst step after oxygen binding (i.e., upon P formation, see
Fig. 2) and this transition is not coupled to proton pumping.
Instead, proton pumping occurs when further electrons are
transferred to the catalytic site and groups with high proton
aﬃnity are formed. In this way, the free energy available from
the oxygen reduction is transiently ‘‘stored’’ in the incom-
pletely protonated oxygen intermediates (see [55]). Below, we
discuss a model in which the exergonic transfer of substrate
protons to the catalytic site is linked to an energy-requiring
structural change, which drives proton pumping.
4.1. Studies on uncoupled mutant forms of CcO
Studies on mutant CcOs, which are capable to reduce oxy-
gen to water but do not pump protons, so-called uncoupled
mutant CcOs, can help us to elucidate the molecular mecha-
nism of proton pumping and its coupling to the driving reac-
tion – the reduction of oxygen. There are two diﬀerent groups
of mutant CcOs in which proton pumping is impaired. In one
group the transfer of substrate protons to the catalytic site is
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not aﬀected (or may even be faster than in the wild-type CcO).
One member of the ﬁrst group is the DN(I-132) mutant CcO
in which proton uptake through the D-pathway is blocked
near the entrance of the pathway (see Fig. 1B). A reversed
respiratory-control ratio was observed with this mutant CcO,
i.e., in contrast to the wild-type CcO, the turnover activity was
higher in the presence of a membrane potential. This obser-
vation was suggested to indicate that protons were taken from
the P-side of the membrane [56]. A mutant CcO with an as-
partate inserted close to E(I-286), in the position of S(I-197),
7 A from the carboxylate group of E(I-286), also resulted in
an enzyme in which proton pumping was uncoupled from
oxygen reduction (Namslauer et al. manuscript in prepara-
tion). The SD(I-197) mutant CcO showed 35% steady-state
activity of that of the wild-type enzyme and was not able to
pump protons. Instead, 0.2 protons per electron were taken
up from the P-side during turnover in experiments in which the
mutant CcO was reconstituted in liposomes.
The second class of mutant CcOs does not exhibit slowed
proton uptake. For example, it was shown that when an as-
paragine, located close to the surface in the D-pathway, was
mutated to an aspartate in CcO from P. denitriﬁcans, the
mutant CcO (ND(I-139), R. sphaeroides CcO numbering, see
Fig. 1B) exhibited full steady-state activity but was not able to
pump protons [57]. The corresponding non-pumping mutant
CcO from R. sphaeroides had approximately two times higher
steady-state activity than the wild-type enzyme [58]. In this
mutant CcO, the rate of the PR ! F transition was the same as
that of the wild-type CcO but the F! O transition rate was
about two times faster [59]. The PR ! F and F! O transi-
tions were both associated with proton uptake from the bulk
solution also in the mutant CcO, and hence the uncoupling
was not due to inhibition of proton uptake through the D-
pathway. Instead, the mutation resulted in an increase in the
observed pKa in the pH dependence of the PR ! F transition
rate from 9.4 to 11, which was attributed to an increase in
the apparent pKa of E(I-286) [59]. Also the pH dependence of
the F! O transition rate was shifted to higher pH values. The
increase in the apparent pKa of E(I-286) may be a result of
electrostatic interactions between E(I-286) and the inserted
aspartate. Alternatively, the insertion of the aspartate results in
altering of the structure of water molecules within the D-
pathway. The alteration is mediated through the pathway and
results in a change in the local environment of E(I-286). Below, 
 
Fig. 5. An illustration of the mechanism of proton pumping discussed in th
acceptor at the catalytic site. The pT is mediated by water molecules (>) thro
and the pump site.we discuss these results in terms of a model for proton
pumping by CcO (see also [60] and [59]).
4.2. Description of a mechanistic model for transfer of pumped
protons
According to the model, E(I-286) constitutes the branching
point for substrate and pumped protons. The pump site is a
group in the region around the D-ring propionates, R(I-481)
and R(I-482) (see above). Initially, E(I-286) is protonated and
hydrogen bonded to the carbonyl oxygen of M(I-107). The
pump site is stabilised in its deprotonated state, i.e., the pump
site has a pKa that is lower than the pH of the bulk solution on
the P-side. The mechanism of proton pumping is described as a
sequence of the following steps (see Fig. 5).
(1) A substrate proton is transferred from E(I-286) to a proton
acceptor at the catalytic site (B in Fig. 5), formed upon eT
from haem a. The reaction is associated with a structural
change of the E(I-286) side chain in which the hydrogen
bond to the carbonyl oxygen of M(I-107) is broken. The
structural change is transmitted to the region around the
pump site (A in Fig. 5). The enzyme is now in a ‘‘pro-
ton-input conformation’’ in which there is a hydrogen-
bonded connection between the pump site and the bulk
solution on the N-side. The conformational change results
in an increased pKa value of the pump site. This step is
rate-limiting for the overall reaction.
(2) While the enzyme is still in the ‘‘proton-input conforma-
tion’’ a proton is rapidly taken up from the bulk solution
through the D-pathway and is transferred to the pump
site (A), which in this state has a pKa value that is high-
er than that of E(I-286).
(3) E(I-286) is reprotonated from the bulk solution and the
structure relaxes to the initial conformation. The pKa value
of the pump site (AH) decreases and the pumped proton is
expelled to the P-side.
It should be noted that there are proton-pumping haem-
copper oxidases that lack the glutamate corresponding to E(I-
286). It has been suggested that in these oxidases, the role of
E(I-286) is taken over by other amino-acid residues, e.g., a
glutamate in a diﬀerent position in the primary structure, but
with a similar position in the three dimensional structure
[47,61], or by a tyrosine-serine motif [62–64].
A fundamental diﬀerence between this model and other
suggested models is the order of protonation events. A priori,
there is a prerequisite that, in each pumping step, the protone text. A(H) represents the pump site and B(H) represents the proton
ugh the D-pathway (shaded box) and from E(I-286) to the catalytic site
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substrate proton reaches the catalytic site. If this would not be
the case, the energy from the oxygen reduction would be lost.
In the model presented here, the substrate proton is transferred
to the catalytic site before the pumped proton is transferred to
the pump site. The free energy available from the reduction of
oxygen is conserved because the exergonic transfer of the
substrate proton to the catalytic site is linked to an endergonic
structural change. This scenario is supported by the observa-
tion that the F intermediate is formed with the same rate in the
DN(I-132) mutant (in which proton uptake from the bulk
solution is impaired) as in the wild-type CcO, which indicates
that the internal proton available at E(I-286) is initially
transferred to the catalytic site and not to the pump site, at
least during the PR ! F transition [49,50].
The transfer of the substrate proton to the catalytic site
before the transfer of the pumped proton makes the proton
pumping sensitive to any changes in the relative rates of pro-
tonation of the pump site and reprotonation of E(I-286), which
is associated with the relaxation of the structure. Below, var-
ious aspects of the model are discussed in more detail and also
in terms of experimental data.4.3. Data supporting the deprotonation of E(I-286) being
associated with structural changes
In the crystal structure of wild-type CcO from R. sphaeroides
at pH 6, the OH group of the protonated E(I-286) is hydrogen-
bonded to the carbonyl oxygen of M(I-107) [11]. There is also
a salt bridge between the D-ring propionate of haem a3 and
R(I-481) that stabilises the propionate in its deprotonated state
(i.e., gives it a low pKa value). In the crystal structure obtained
with the wild type CcO at pH 10 and that of the EQ(I-286)
mutant CcO, the hydrogen bond between E(I-286) and M(I-
107) is lost and the conformation of the E(I-286) side chain is
altered. In addition, there are structural changes in the area
around the arginines ((R(I-481) and R(I-482)) and the haem
propionates (cf. Fig. 1B). The distance between the D-ring
propionate of haem a3 and R(I-481) is increased and a water
molecule enters between the two groups. The movement of this
water molecule results in breaking of the salt bridge between
R(I-481) and the D-ring propionate resulting in an increased
pKa of the propionate. Hence, there seems to be a structural
link between the deprotonation of E(I-286) and the assumed
pump site that may result in an increased proton aﬃnity of the
D-ring propionate when E(I-286) is deprotonated. It is likely
that the same type of structural changes occur transiently
during catalytic turnover when a proton is transferred from
E(I-286) to the catalytic site. A structural change, linked to the
deprotonation of E(I-286), is also supported by results from
investigations of the kinetic solvent deuterium isotope eﬀect of
the F! O transition [46,65]. The kinetic deuterium isotope
eﬀect of the transition is large (kH=kD ﬃ 7) and the results from
D2O-fractionation experiments indicate that the entire isotope
eﬀect is associated with a single protonatable site suggested to
be E(I-286), which undergoes a structural change before the pT
occurs [46,65].4.4. How is an increased pKa value of E(I-286) correlated to the
impaired proton pumping
According to the model, the proton pumping eﬃciency de-
pends on the relative rates of pT from the bulk solution to thepump site and the reprotonation of E(I-286), which is associ-
ated with a structural relaxation. These rates depend on the
relative pKa values of E(I-286) and the pump site in the ‘‘pro-
ton-input conformation’’. The uptake of a proton to the pump
site requires that the proton taken up from the bulk solution
in step 2 (see Fig. 5) is transferred to the pump site before
reprotonation of E(I-286) and relaxation of the structure.
The proton acceptor at the catalytic site during the PR ! F
transition presumably has a pKa value that is P 12 [59]. A high
pKa value of the proton acceptor is expected because the pT to
the catalytic site drives the proton pumping. It is assumed that
the pKa value of the pump site is lower. In e.g., the ND(I-139)
mutant CcO, the increased pKa value of E(I-286) results in an
altered proton equilibrium between E(I-286) and the pump
site, i.e., the proton is stabilised on E(I-286). Therefore, E(I-
286) becomes reprotonated, allowing the structure to relax,
before the pumped proton is transferred to the pump site.4.5. The functional role of haem a
Several proton pumping models have been suggested in
which reduction/oxidation of haem a is coupled to protonation/
deprotonation of a pump site (see e.g. [36,37,69–73]). It has also
been proposed that the redox state of haem a controls the
structure of the water molecules connecting E(I-286) with the
D-ring propionate of haem a3 and the catalytic site, thereby
providing a mechanism of proton gating [19]. Experimental
data on proton uptake/release upon haem a reduction/oxida-
tion is in many cases contradictory, varying between 0.2 and 1
proton per electron (see e.g. [36,37,69–73]. It has been shown
that during the PR ! F transition, haem a is not reduced by
CuA unless a proton is taken up from the bulk solution to
reprotonate E(I-286), indicating an interaction between haem a
and E(I-286) [49–51]. In other words, the eT is controlled by the
pT. Hence, the role of haem a may be to control the timing of
eT from cytochrome c/CuA to the catalytic site, such that eT to
the catalytic site is prevented before E(I-286) is reprotonated.
Since the pKa of E(I-286) is P 9, its protonation state does not
change upon haem a reduction/oxidation when measurements
are done below pH 9, but there may still be a strong elec-
trostatic interaction between E(I-286) and haem a, which is
observed only transiently when E(I-286) is deprotonated, e.g.
during the PR ! F transition.4.6. Summary: proton translocation through the D-pathway
There are two diﬀerent reasons for uncoupled proton
pumping from oxygen reduction: (i) If the proton uptake
through the D-pathway from the bulk solution on the N-side is
impaired, then rapid protonation of the pump site and E(I-286)
is not possible and the enzyme stays in the ‘‘proton-input
conformation’’, with E(I-286) deprotonated, after the internal
pT to the catalytic site. In this state there may be a higher
probability for slow proton uptake, via the pump site and E(I-
286), from the P-side of the membrane (cf. results obtained with
the SD(I-197) and DN(I-132) mutant CcOs, discussed above).
The slow uptake of substrate protons results in slowed oxygen
reduction and steady-state activities. (ii) If electrostatic and/or
structural changes within the D-pathway result in an increased
pKa of E(I-286), then the delivery of substrate protons from the
N-side to the binuclear centre can still be rapid and the oxygen
reduction rate is not decreased. In this case the proton equi-
librium between E(I-286) and the pump site is aﬀected, stabil-
A. Namslauer, P. Brzezinski / FEBS Letters 567 (2004) 103–110 109ising the proton on E(I-286), and therefore the eﬀective rate of
protonation of the pump site is too slow to maintain proton
pumping. We suggest that this is the case with the ND(I-139)
[58,59] and ND(I-207) (Namslauer et al. unpublished data)
mutant CcOs. Thus, eﬃcient proton pumping in CcO relies on
both rapid proton uptake (through the D-pathway) from the
bulk solution on the N-side and ﬁnely tuned pKa values of the
proton shuttling groups within the enzyme.References
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